Goker-Alpan O - Search Results

1

Clinical course and prognosis in patients with Gaucher disease and parkinsonism.

Lopez G, Kim J, Wiggs E, Cintron D, Groden C, Tayebi N, Mistry PK, Pastores GM, Zimran A, Goker-Alpan O, Sidransky E. Lopez G, et al. Neurol Genet. 2016 Mar 4;2(2):e57. doi: 10.1212/NXG.0000000000000057. eCollection 2016 Apr. Neurol Genet. 2016. PMID: 27123476 Free PMC article.

2

Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.

Goker-Alpan O, Schiffmann R, Park JK, Stubblefield BK, Tayebi N, Sidransky E. Goker-Alpan O, et al. J Pediatr. 2003 Aug;143(2):273-6. doi: 10.1067/S0022-3476(03)00302-0. J Pediatr. 2003. PMID: 12970647

3

Glucocerebrosidase mutations in subjects with parkinsonism.

Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E. Lwin A, et al. Mol Genet Metab. 2004 Jan;81(1):70-3. doi: 10.1016/j.ymgme.2003.11.004. Mol Genet Metab. 2004. PMID: 14728994

4

Parkinsonism among Gaucher disease carriers.

Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Goker-Alpan O, et al. J Med Genet. 2004 Dec;41(12):937-40. doi: 10.1136/jmg.2004.024455. J Med Genet. 2004. PMID: 15591280 Free PMC article.

5

Divergent phenotypes in Gaucher disease implicate the role of modifiers.

Goker-Alpan O, Hruska KS, Orvisky E, Kishnani PS, Stubblefield BK, Schiffmann R, Sidransky E. Goker-Alpan O, et al. J Med Genet. 2005 Jun;42(6):e37. doi: 10.1136/jmg.2004.028019. J Med Genet. 2005. PMID: 15937077 Free PMC article.

6

Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum.

Eblan MJ, Goker-Alpan O, Sidransky E. Eblan MJ, et al. Fetal Pediatr Pathol. 2005 Jul-Oct;24(4-5):205-22. doi: 10.1080/15227950500405296. Fetal Pediatr Pathol. 2005. PMID: 16396828 Review.

7

Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease.

Holleran WM, Ziegler SG, Goker-Alpan O, Eblan MJ, Elias PM, Schiffmann R, Sidransky E. Holleran WM, et al. Clin Genet. 2006 Apr;69(4):355-7. doi: 10.1111/j.1399-0004.2006.00589.x. Clin Genet. 2006. PMID: 16630170 No abstract available.

8

Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism.

Eblan MJ, Scholz S, Stubblefield B, Gutti U, Goker-Alpan O, Hruska KS, Singleton AB, Sidransky E. Eblan MJ, et al. Neurosci Lett. 2006 Aug 14;404(1-2):163-5. doi: 10.1016/j.neulet.2006.05.032. Epub 2006 Jun 15. Neurosci Lett. 2006. PMID: 16781064

9

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.

Goker-Alpan O, Giasson BI, Eblan MJ, Nguyen J, Hurtig HI, Lee VM, Trojanowski JQ, Sidransky E. Goker-Alpan O, et al. Neurology. 2006 Sep 12;67(5):908-10. doi: 10.1212/01.wnl.0000230215.41296.18. Epub 2006 Jun 21. Neurology. 2006. PMID: 16790605

10

Gaucher disease and the synucleinopathies.

Hruska KS, Goker-Alpan O, Sidransky E. Hruska KS, et al. J Biomed Biotechnol. 2006;2006(3):78549. doi: 10.1155/JBB/2006/78549. J Biomed Biotechnol. 2006. PMID: 17047314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters